Artwork

محتوای ارائه شده توسط Executive Platforms. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Executive Platforms یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Controlling Costs through Continuous Manufacturing of Biopharmaceuticals — A Conversation with Jon Gunther of Just – Evotec Biologics

21:53
 
اشتراک گذاری
 

Manage episode 424223851 series 3580470
محتوای ارائه شده توسط Executive Platforms. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Executive Platforms یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

At the 2023 edition of the Biomanufacturing World Summit series we sat down with Jon Gunther of Just – Evotec Biologics to talk about why biopharmaceutical manufacturing is behind the curve when it comes to controlling its costs, and what lessons senior leaders can take from other industries as they work to rein in expenses. One important idea explored at length is the advantage pivoting from batch manufacturing to continuous manufacturing would offer the Life Sciences in terms of reducing operating costs, costs of goods, labor costs, and more. What does making that switch look like in real terms? What do companies need to do to prepare their people, processes, and systems for change, and who can they look to for guidance and assistance as they transform themselves? How can companies model their product workflow and output before committing themselves to the transition, and what kind of platform will allow for the smoothest possible move between production models? Give this episode a listen for answers to these questions and more!

--

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com

  continue reading

218 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 424223851 series 3580470
محتوای ارائه شده توسط Executive Platforms. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Executive Platforms یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

At the 2023 edition of the Biomanufacturing World Summit series we sat down with Jon Gunther of Just – Evotec Biologics to talk about why biopharmaceutical manufacturing is behind the curve when it comes to controlling its costs, and what lessons senior leaders can take from other industries as they work to rein in expenses. One important idea explored at length is the advantage pivoting from batch manufacturing to continuous manufacturing would offer the Life Sciences in terms of reducing operating costs, costs of goods, labor costs, and more. What does making that switch look like in real terms? What do companies need to do to prepare their people, processes, and systems for change, and who can they look to for guidance and assistance as they transform themselves? How can companies model their product workflow and output before committing themselves to the transition, and what kind of platform will allow for the smoothest possible move between production models? Give this episode a listen for answers to these questions and more!

--

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com

  continue reading

218 قسمت

すべてのエピソード

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع